Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV) from United States
Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV) is a purified immunoglobulin fraction derived from human plasma of donors with high CMV antibody titers. It is used prophylactically to prevent CMV infection in transplant patients. This product falls under tariff item 3002.12.00 as a blood fraction prepared for therapeutic or prophylactic uses.
Duty Rate — United States → Canada
0%
Import Tips
• Obtain a Health Canada import authorization for the immunoglobulin product before shipping
• Ensure proper cold chain documentation is provided to CBSA
• Classify the product as a blood fraction under tariff item 3002.12.00